SAN DIEGO, Nov. 5, 2010 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that company management will present an overview of the company at the following conferences in November.
(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO)
- Lazard Capital Markets 7th Annual Healthcare Conference
- Location: The St. Regis, New York, NY
- Presentation date: Tuesday November 16, 2010
- Presentation time: 11:25am ET
- Presenter: Harry F. Hixson Jr PhD, Chairman and CEO
- Stephens Fall Investment Conference
- Location: The Palace Hotel, New York, NY
- Presentation date: Wednesday November 17, 2010
- Presentation time: 1:00pm ET
- Presenter: Harry F. Hixson Jr PhD, Chairman and CEO
A live webcast and 30-day archive of these presentations will be available at http://ir.sequenom.com.
About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a website at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom website to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.
SOURCE Sequenom, Inc.
